PDGF-induced proliferation in human arterial and venous smooth muscle cells: Molecular basis for differential effects of PDGF isoforms

Journal of Cellular Biochemistry

Volumn 112, Issue 1, 2011, Pages 289-298

  Li, Li ^a   Blumenthal, Donald K ^b   Terry, Christi M ^a   He, Yuxia ^a   Carlson, Mary L ^a   Cheung, Alfred K ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arterial and venous SMC; Cell proliferation; Platelet derived growth factor (PDGF); Signaling pathways

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE;

ARTERY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VEIN;

ARTERIES; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FLOW CYTOMETRY; HUMANS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; PROTEIN ISOFORMS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; VEINS;

EID: 78651263899     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22924     Document Type: Article

References (29)

1. Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, Alitalo K, Eriksson U. 2001. PDGF-D is a specific, protease-Activated ligand for the PDGF beta-receptor. Nat Cell Biol 3:512-516.
2. Choudhury GG, Grandaliano G, Jin DC, Katz MS, Abboud HE. 2000. Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. Kidney Int 57:908-917.
3. Hachida M, Zhang X, Lu H, Hoshi H, Furutani Y, Matsuoka R, Koyanagi H. 1998. Association between the degree of platelet-derived growth factor-A chain mRNA expression and coronary arteriosclerosis in the transplanted heart. Heart Vessels 13:24-29. (Pubitemid 28566023)
4. Hachida M, Zhang X, Lu H, Hoshi H, Koyanagi H. 1999. Effects of immunosuppressants on platelet-derived growth factor-A chain mRNA expression and coronary arteriosclerosis in rat cardiac allografts. Jpn Circ J 63:303-308.
5. Hackel PO, Zwick E, Prenzel N, Ullrich A. 1999. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11:184-189.
6. Hart CE, Bailey M, Curtis DA, Osborn S, Raines E, Ross R, Forstrom JW. 1990. Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry 29:166-172.
7. Heldin CH, Westermark B. 1999. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283-1316.
8. Heldin CH, Ostman A, Ronnstrand L. 1998. Signal transduction via plateletderived growth factor receptors. Biochim Biophys Acta 1378:F79-F113.
9. Karvinen H, Rutanen J, Leppanen O, Lach R, Levonen AL, Eriksson U, Yla- Herttuala S. 2009. PDGF-C and -D and their receptors PDGFR-Alpha and PDGFR-beta in atherosclerotic human arteries. Eur J Clin Invest 39:320-327.
10. LaRochelleWJ, Jeffers M, McDonaldWF, Chillakuru RA, Giese NA, Lokker NA, Sullivan C, Boldog FL, Yang M, Vernet C, Burgess CE, Fernandes E, Deegler LL, Rittman B, Shimkets J, Shimkets RA, Rothberg JM, Lichenstein HS. 2001. PDGF-D, a new protease-Activated growth factor. Nat Cell Biol 3:517-521.
11. Li X, Ponten A, Aase K, Karlsson L, Abramsson A, Uutela M, Backstrom G, Hellstrom M, Bostrom H, Li H, Soriano P, Betsholtz C, Heldin CH, Alitalo K, Ostman A, Eriksson U. 2000. PDGF-C is a new protease-Activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2:302-309.
12. Li L, Blumenthal DK, Masaki T, Terry CM, Cheung AK. 2006a. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells. J Cell Biochem 99:1553-1563.
13. Li Y, Fukuda N, Kunimoto S, Yokoyama S, Hagikura K, Kawano T, Takayama T, Honye J, Kobayashi N, Mugishima H, Saito S, Serie K. 2006b. Stent-based delivery of antisense oligodeoxynucleotides targeted to the PDGF A-chain decreases in-stent restenosis of the coronary artery. J Cardiovasc Pharmacol 48:184-190.
14. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, Golding LA, Gill CC, Taylor PC, Sheldon WC, Proudfit WL. 1986. Influence of the internal-mammary-Artery graft on 10-year survival and other cardiac events. N Engl J Med 314:1-6.
15. Motwani JG, Topol EJ. 1998. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 97:916-931.
16. Nilsson J, Sjolund M, Palmberg L, Thyberg J, Heldin CH. 1985. Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci USA 82:4418-4422. (Pubitemid 15234245)
17. Okamoto K, Kato S, Arima N, Fujii T, Morimatsu M, Imaizumi T. 2004. Cyclindependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy. Hypertens Res 27:283-291.
18. Raines EW. 2004. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15:237-254.
19. Reigstad LJ, Varhaug JE, Lillehaug JR. 2005. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the plateletderived growth factors family. FEBS J 272:5723-5741.
20. Sachinidis A, Schulte K, Ko Y, Meyer zu Brickwedde MK, Hoppe V, Hoppe J, Vetter H. 1993. The induction of early response genes in rat smooth muscle cells by PDGF-AA is not sufficient to stimulate DNA-synthesis. FEBS Lett 319:221-224.
21. Saito Y, Haendeler J, Hojo Y, Yamamoto K, Berk BC. 2001. Receptor heterodimerization: Essential mechanism for platelet-derived growth factor- induced epidermal growth factor receptor transactivation. Mol Cell Biol 21:6387-6394.
22. Sanchez-Tillo E, Comalada M, Xaus J, Farrera C, Valledor AF, Caelles C, Lloberas J, Celada A. 2007. JNK1 is required for the induction of Mkp1 expression in macrophages during proliferation and lipopolysaccharidedependent activation. J Biol Chem 282:12566-12573.
23. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, Kawai- Kowase K, Moriyama N, Imai Y, Kawakami H, Nishimatsu H, Ishikawa T, Suzuki T, Morita H, Maemura K, Sata M, Hirata Y, Komukai M, Kagechika H, Kadowaki T, Kurabayashi M, Nagai R. 2002. Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 8:856-863.
24. US Renal Data System. 2007. 2007 USRDS annual report. Minneapolois: United States Renal Data System.
25. Wagsater D, Zhu C, Bjorck HM, Eriksson P. 2009. Effects of PDGF-C and PDGF-D on monocyte migration and MMP-2 and MMP-9 expression. Atherosclerosis 202:415-423.
26. Weiss S, Frischknecht K, Greutert H, Payeli S, Steffel J, Luscher TF, Carrel TP, Tanner FC. 2007. Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathway. J Vasc Res 44:149-156.
27. Yang Z, Oemar BS, Carrel T, Kipfer B, Julmy F, Luscher TF. 1998. Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: Role of PDGF receptors, mitogen-Activated protein kinase, and cyclin-dependent kinase inhibitors. Circulation 97:181-187.
28. Yu J, Deuel TF, Kim HR. 2000. Platelet-derived growth factor (PDGF) receptor-Alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta-induced phenotypic transformation. J Biol Chem 275: 19076-19082.
29. Yu J, Liu XW, Kim HR. 2003. Platelet-derived growth factor (PDGF) receptoralpha- activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1/CIP1 promoter activity independent of p53. J Biol Chem 278: 49582-49588.